LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 96-WEEK OUTCOMES OF THE RAPID-AXSPA TRIAL

Author(s):
Sieper, J.; Rudwaleit, M.; Heijde, D. van der; Maksymowych, W.P.; Dougados, M.; Mease, P.J.; Reveille, J.; Braun, J.; Deodhar, A.; Arledge, T.; Nurminen, T.; Landewe, R.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Clinical and Experimental Rheumatology (2014), Vol. 32, no. 5, p. 785-786
hdl
1887/103504